Catalent, Inc. (NYSE:CTLT) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Catalent Incorporation Fourth Quarter Fiscal Year 2023 Earnings Conference Call. My name is Glen.
Catalent Inc. (CTLT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Corvex Capital Keith Meister | 5,670,297 | $245,864,078 | 12.09% | |
| 2. | Leonard Green & Partners Leonard Green | 4,342,441 | $188,288,242 | 3.08% | |
| 3. | Cadian Capital Eric Bannasch | 2,778,034 | $120,455,554 | 5.69% | |
| 4. | Castle Hook Partners Josh Donfeld And David Rogers | 1,729,410 | $74,987,218 | 2.22% | |
| 5. | Redmile Group Jeremy Green | 1,162,166 | $50,391,518 | +91% | 1.93% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.98 | 1,000 | Director | 1,979 | 2023-08-31 | Filing | |
| $50.24 | 21,000 | Officer, Director | 34,000 | 2023-08-30 | Filing | |
| $59.71 | 2,000 | Director | 40,921 | 2020-02-13 | Filing | |
| $51.64 | 2,000 | Director | 38,921 | 2019-09-09 | Filing | |
| $45.13 | 44,500 | Officer | 44,500 | 2019-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $45.15 | 101 | Officer, Director | 88,004 | 2023-08-24 | Filing | |
| $44.51 | 1,970 | Officer, Director | 88,105 | 2023-08-24 | Filing | |
| $44.57 | 269 | Officer | 29,932 | 2023-08-24 | Filing | |
| $44.50 | 390 | Officer | 24,449 | 2023-08-24 | Filing | |
| $44.49 | 396 | Officer | 96,552 | 2023-08-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,102,379 | $871,639,153 | 0.02% | |
| 2. | 15,960,335 | $692,040,126 | 0.13% | |
| 3. | 14,918,877 | $646,882,507 | 0.01% | |
| 4. | 14,737,435 | $639,019,334 | 0.39% | |
| 5. | 8,436,425 | $365,803,388 | 0.98% |
News See All
Hedge Fund and Insider Trading News: Elliott Investment Management, Millennium Management, Citadel LLC, Capstone Investment Advisors, HF Foods Group Inc (HFFG), Impinj, Inc. (PI), and More
Contract drug maker Catalent Inc (CTLT.N) said on Tuesday it had added four new directors to its board and will conduct a strategic review after reaching a settlement with activist investor Elliott Investment...
Catalent (CTLT) Declined on Disappointing Execution
Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Is it a Good Time to Dispose Your Catalent (CTLT) Shares?
Aristotle Atlantic Partners, an investment management firm, released its second quarter 2023 investor letter, a copy of which can be downloaded here.
5 Best Healthcare Stocks Under $50
In this article, we will be taking a look at the 5 best healthcare stocks under $50.
Viking Global's Performance, AUM, and Long-Term Stock Picks
In this article, we discuss Viking Global's performance, AUM, and 10 long-term stock picks.
Does Catalent (CTLT) have an Opportunity for Long-Term Value Creation?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Catalent (CTLT) Rebounded from Low Post-COVID Valuations
Mairs & Power, an investment advisor, released “Mairs & Power Small Cap Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Catalent, Inc. (NYSE:CTLT) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Catalent, Inc.
Catalent (CTLT) Declined on Lowered Guidance
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
